Comparison of different methods to measure fibrinogen concentration in canine plasma with respect to their sensitivity towards the fibrinogen degradation products X, Y and D

Haemostasis

Volumn 30, Issue 3, 2000, Pages 131-138

  Mischke, R ^a,b   Menzel, D ^a   Wolling, H ^a  

^a School of Veterinary Medicine   (Germany)

^b UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

Author keywords

Clauss method; Dog; Fibrinogen degradation products X, Y, D; Fibrinogen determination; In vitro sensitivity; Jacobsson method; Photometric method

Indexed keywords

FIBRINOGEN DEGRADATION PRODUCT;

ARTICLE; BLOOD CLOTTING; CONCENTRATION RESPONSE; DOG; FIBRINOGEN BLOOD LEVEL; INTERMETHOD COMPARISON; NONHUMAN; PHOTOMETRY; PRIORITY JOURNAL;

EID: 0033802947     PISSN: 03010147     EISSN: None     Source Type: Journal    
DOI: 10.1159/000022535     Document Type: Article

References (22)

1. Spannagl M, Schramm W: Klinische Erprobung eines kinetischen Trübungstestes zur Fibrinogenbestimmung. Lab Med 1987;11:123-127.
2. Dessauer A, Spanuth E, Bartl K: Photometrische Fibrinogenbestimmung mit einem kinetischen Trübungstest. Lab Med 1986;10:287-290.
3. Hoffmann M, Greenberg CS: The effect of fibrin polymerisation inhibitors on quantitative measurements of plasma fibrinogen. Am J Clin Pathol 1987;88:490-493.
4. Jacobsson K: Studies on fibrinogen: I. Studies on the determination of fibrinogen in human blood plasma. Scand J Clin Lab Invest 1955;7:1-54.
5. Clauss A: Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol 1957;17:237-246.
6. Hemker HC, Kop J, Williams GM: The relation between clotting time and clotting velocity. Thromb Haemost 1979;41:309-313.
7. Becker U, Bartl K, Wahlefeld AW: A functional photometric assay for plasma fibrinogen. Thromb Res 1984;35:475-484.
8. Wolling H, Mischke R: Präparation und Reinigung von Milligramm-Mengen der caninen Fibrinogen-spaltprodukte (FSP) -X, -Y, -D und -E. Berl Münch Tierärztl Wochenschr 1995;108:421-426.
9. Kazal LA, Amsel S, Miller OP, Tocantins LM: The preparation and some properties of fibrinogen precipitated from human plasma by glycine. Proc Soc Exp Biol Med 1963;113:989-994.
10. Heukeshoven J, Dernick R: Improved silver staining procedure for fast staining in PhastSystem development unit. I. Staining of sodium dodecyl sulfate gels. Electrophoresis 1988;9:28-32.
11. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72: 248-254.
12. Hirsh J, Fletcher AP, Sherry S: Effect of fibrin and fibrinogen proteolysis products on clot physical properties. Am J Physiol 1965;209: 415-424.
13. Donati MB, Vermylen J, Verstracte M: Fibrinogen degradation products and a fibrinogen assay based on clotting kinetics. Scand J Haematol 1971;8(suppl 13):255-256.
14. Bick RL, McClain BJ: A comparison of Dade and DuPont fibrinogen assays in patients with DIC. thromboembolic diseases and during thrombolytic therapy. Am J Clin Pathol 1984;82:372.
15. Lurie AA, Gross LF, Rogers WF: The measurement of fibrinogen by the DuPont aca and Dade methods in patients receiving streptokinase infusions. Am J Clin Pathol 1985; 84:526-529.
16. Walker AN, Pope WT: Discrepant fibrinogen values during thrombolytic therapy: Comparison of aca® and Data-Fi® results using immuno-fixation electrophoresis as a reference. Am J Clin Pathol 1985;84: 485-489.
17. Mischke R, Wohlsein P, Busse L, Pohlenz J: Verbrauchskoagulopathic und Hyperfibrinolyse bei Hunden mit metastasierendem Mammakarzinom. Schweiz Arch Tierheilkd 1998;140:497-505.
18. Marder VJ, Shulman NR: High molecular weight derivatives of human fibrinogen produced by plasmin: II. Mechanism of their anticoagulant activity. J Biol Chem 1969;244: 2110-2124.
19. Haverkate F, Timan G, Nieuwenhuizen W: Anticlotting properties of fragments D from human fibrinogen and fibrin. Eur J Clin Invest 1979;9: 253-255.
20. Nieuwenhuizen W, Voskuilen M, Hermans J: Anticoagulant and calcium-binding properties of high molecular weight derivatives of human fibrinogen (plasmin fragments Y). Biochim Biophys Acta 1982;708: 313-316.
21. Gaffney PJ: Fibrin(-ogen) interactions with plasmin. Haemostasis 1977;6:2-25.
22. Marder VJ, Shulman NR: High molecular weight derivatives of human plasmin produced by plasmin. I. Physicochemical and immunological characterization. J Biol Chem 1969;244:2111-2119.